Skip to main content
. 2021 Feb 26;7(2):e22483. doi: 10.2196/22483

Figure 4.

Figure 4

Therapeutics chosen by the respondents to be most likely to succeed in treating COVID-19. § Umifenovir (0.69%); ¢ Unknown antimalarial (0.20%); ª Mefloquine (0.10%); + Chloroquine (0.10%); $ Other antibiotic (0.10%); * Losartan (0.10%); º Captopril (0.10%); @ Bevacizumab (0.20%); £ Acalabrutinib (0.10%); # Other kinase inhibitor (0.10%); ¬ Other nondrug (0.10%).